Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 15, 2017 |
| Target | Rosetta Genomics |
| Sector | Life Science |
| Buyer(s) | Genoptix |
| Deal Type | Add-on Acquisition |
| Deal Value | 10M USD |
| Advisor(s) | Cantor Fitzgerald (Financial) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Healthcare Services |
| Employees | 508 |
Genoptix, Inc. is one of the largest hematopathology testing laboratories in the U.S., providing thousands of oncologists and pathologists across the United States with comprehensive testing solutions in hematology and solid tumor molecular profiling. Genoptix, Inc. was founded in 1999 and is based in Carlsbad, California.
| Deal Context for Buyer | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science | 1 of 2 |
| Type: Add-on Acquisition | 2 of 2 |
| Country: Israel | 1 of 1 |
| Year: 2017 | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-09-19 |
HistoRx
Branford, Connecticut, United States HistoRx provides a solution to the need for quantitative, standardized and reproducible analysis of protein biomarkers in tissue. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-03-05 |
PersonalizeDx
Lake Forest, California, United States PersonalizeDx Labs provides as a service molecular tests in pharmacogenomics, genetic disorders, oncology and infectious disease which will serve as a valuable aid for clinicians in diagnosing patients early and enable appropriate therapeutic intervention to enhance patient care. |
Buy | $1M |
